Author

Giulio Zanette

Centre Hospitalier Universitaire VaudoisPrimary ORCID profile (0009-0006-9116-0262 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Giulio ZanetteiD1 paper · Karolinska Institutet

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Camilla JandusiD· 1 shared Daniel A. BenamraniD· 1 shared Emma DespondsiD· 1 shared Grégory VerdeiliD· 1 shared Hajar El AhanidiiD· 1 shared Hana ZdimerovaiD· 1 shared Hélène Maby-El HajjamiiD· 1 shared Julien DagheriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Camilla JandusORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

Emma Desponds, Hajar El Ahanidi, Nagham Alouche, Hana Zdimerova, Stéphanie Favre, Giulio Zanette, Sina Nassiri, Daniel A. Benamran, Petros K. Tsantoulis, Mohammed Attaleb, Hélène Maby-El Hajjami, Julien Dagher, Vanessa Gourhand, Karl Balabanian, Marion Espéli, , Grégory Verdeil

This study identifies CXCR4-expressing tumor-associated macrophages in bladder cancer and shows that targeting them improves immunotherapy outcomes in mice and patients.

bioRxiv · Mar 21, 2025 · PreprintImmunology